CPHI MILAN 2024 WHAT’S NEW AT CPHI MILAN 2024 Standing on the shoulders of 35 pharma and science champions CPHI has grown dramatically over the last three and half decades. Alongside this, the advancement of the pharma industry has been even more impressive, with contribu- tions to global innovation and human health growing exponentially. The FDA is now regularly approving over 50 new medicines each year, reaching an all-time high 73 in 2023 – including the first ever CRISPR–Cas9-edited therapy and a disease-modifying Alzheimer’s drug. As we celebrate these prestigious innovations – that you, our attendees, directly con- tribute to –CPHI acknowledges that what is possible today is built on the shoulders of the giants of science from yesterday. Throughout the show-floor we’ll be promoting the achievements of 35 heroes of pharma and science. This will span historical greats like Edward Jenner (smallpox vaccine), Alexander Fleming (Penicillin), and Paul Ehrlich – the founding father of immunotherapy – to more recent champions like Robert Langer (nanomedicine), Carl June (CAR-Ts) and Özlem Türeci (mRNA vaccine). There will be a number of onsite programmes related to this celebration, so come together in Milan and celebrate everything the industry has achieved…. and look ahead to everything we can achieve tomorrow. Troghuh dee ppartnerships and collaborations many of these recent advances have been made possible, a legacy we look to continue as the industry comes together. Supply Chain Resilience Stay ahead with insights into new technologies and strategies essential for diversifying and stabilising the supply chain. CPHI Milan 2024 will showcase the latest innovations and practical solutions to navigate the complexities of the pharmaceutical landscape. The event will focus on strategies for mitigating risks, ensuring continuity, and opti- mising operations within the supply chain, all of which are crucial in today's volatile market environment. CPHI Celebration On October 8th at Fiera in Hall 1, the CPHI Celebration awards night will commence with a glamorous drinks reception, celebrating excellence and innovation in the phar- maceutical industry across 14 categories. Among the highlights is the new "Woman of the Year" award, honouring women leaders who inspire colleagues, champion di- versity and inclusion, and advocate for industry progression. Nominees are evaluated on their leadership, collaboration, and ability to create opportunities for women while challenging the status quo. Equally anticipated is the novel "Future Leader" award, recognising rising stars under 35 with at least five years of experience in pharma, biopharma, or academic institutions. This award celebrates those who bring fresh perspectives, manage teams effectively, and introduce innovative ideas, marking them as the future leaders set to shape the pharmaceutical industry with their dedication and vision.